Home › Products › Ion Channels › K+ Channels › Inward Rectifier K+ Channels › Antibodies to Kir Channels

Anti-GIRK2 (Kir3.2) Antibody

G protein-activated inward rectifier potassium channel 2, Kcnj6
    Cat #: APC-006
  • Lyophilized Powder
  • Antigen Incl.
  • Shipped at Room Temp.
    • Type: Polyclonal
    Source: Rabbit
    Reactivity: h, m, r
    Immunogen
    GST fusion protein with sequence ELANRAEVPLSWSVS SKLNQHAELETEEEEKNPEELTERNG, corresponding to residues 374-414 of mouse Kir3.2 (Accession P48542), (MW: 31 kDa.). Intracellular, C-terminal part.
    Accession (Uniprot) Number P48542
    Gene ID 16522
    Peptide confirmation Confirmed by DNA sequence and SDS-PAGE.
    Homology Rat - 40/41 amino acid residues identical; golden hamster - 39/41 amino acid residues identical; human - 37/41 amino acid residues identical.
    Purity The serum was depleted of anti-GST antibodies by affinity chromatography on immobilized GST and then the IgG fraction was purified on immobilized antigen.
    Formulation Lyophilized powder. Reconstituted antibody contains phosphate buffered saline (PBS), pH 7.4, 1% BSA, 0.025% NaN3.
    Storage before reconstitution The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.
    Reconstitution 25 µl, 50 µl or 0.2 ml double distilled water (DDW), depending on the sample size.
    Antibody concentration after reconstitution 0.8 mg/ml.
    Storage after reconstitution The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).
    Control antigen storage before reconstitution Lyophilized powder can be stored intact at room temperature for 2 weeks. For longer periods, it should be stored at -20°C.
    Control antigen reconstitution 100 µl double distilled water (DDW).
    Control antigen storage after reconstitution -20°C.
    Preadsorption Control 3 µg fusion protein per 1 µg antibody.
    Standard quality control of each lot Western blot analysis.
    Applications: ic, ih, ip, wb
    May also work in: ifc
    Western blot
    Western blot analysis of rat brain membranes:
    1. Anti-GIRK2 (Kir3.2) Antibody (#APC-006), (1:200).
    2. Anti-GIRK2 (Kir3.2) Antibody, preincubated with the control antigen.
    Immunoprecipitation
    Mouse brain membrane proteins (1:174) (Jelacic, T.M. et al. (2000) J. Biol. Chem. 275, 36211.).
    Immunohistochemistry
    Expression of Kir3.2 in mouse brain
    Immunohistochemical staining of perfusion-fixed frozen mouse substantia nigra pars compacta sections using Anti-GIRK2 (Kir3.2) Antibody (#APC-006), (1:400). GIRK2 staining (red) appears in cells and processes along the pars compacta of the mouse substantia nigra (horizontal arrows) and in the pars reticulata (vertical arrows). Cell nuclei are stained with DAPI (blue).
    Immuno-colocalization of Kir3.2 and KCNK2 in rat substantia nigra
    Immunohistochemical staining of immersion-fixed, free floating rat brain frozen sections using rabbit Anti-GIRK2 (Kir3.2) Antibody (#APC-006), (1:400) and Guinea pig Anti-KCNK2 (TREK-1) Antibody (#AGP-049), (1:120). A. Kir3.2 staining (red) appears in cells of the substantia nigra pars compacta (SNC, arrows). B. KCNK2 (green) appears in both compacta (SNC) and reticulata (SNR) portions of the substantia nigra. C. Merge of the two images reveals co-localization in some cells (arrows), mainly in the SNC region. Cell nuclei are stained with DAPI (blue).
    Mouse spinal cords (Marker, C.L. et al. (2004) J. Neurosci. 24, 2806.).
    Immunocytochemistry
    hVM1 (human ventral mesencephalic neural stem cell line 1 (1:400) (Courtois, E.T. et al. (2010) J. Biol. Chem. 285, 9881.).
    References
    1. Hess, E.J. (1996) Neuron 16, 1073.
    2. Dascal, N. (1997) Cell Signal. 9, 551.
    3. Mark, M.D. et al. (2000) Eur. J. Biochem. 267, 5830.
    4. Kubo, Y. et al. (2005) Pharmacol. Rev. 57, 509.
    Scientific background

    Kir3.2 (or G-protein regulated inward-rectifier K+ channel, GIRK2) is a member of the family of inward rectifying K+ channels. The family includes 15 members that are structurally and functionally different from the voltage-dependent K+ channels.

    The family’s topology consists of two transmembrane domains that flank a single and highly conserved pore region with intracellular N- and C-termini. As is the case for the voltage-dependent K+ channels, the functional unit for the Kir channels is composed of four subunits that can assemble as either homo- or heterotetramers.

    Kir channels are characterized by a K+ efflux that is limited by depolarizing membrane potentials thus making them essential for controlling resting membrane potential and K+ homeostasis.

    Kir3.2 is a member of the Kir3.x subfamily that includes four members (Kir3.1- Kir3.4). The Kir3 family is characterized by the fact that the channels can be activated by neurotransmitters and other factors acting via the activation of G-protein coupled receptors. Binding of the corresponding ligand to the G-protein receptor induces the dissociation of Gα-GTP from the Gbg dimer. The latter directly binds to Kir3 and activates the channel.2,3

    Kir3.2 is mainly expressed in the brain, where it co-assembles with Kir3.1 (GIRK1) or Kir3.3 (GIRK3) and mediates the inhibitory effects of many neurotransmitters including opioid, adrenergic, muscarinic, dopaminergic and GABAergic neurotransmitters.2,3

    Point mutations in the mouse Kir3.2 channel cause the weaver (wv) phenotype, a neurological abnormality characterized by the abnormal ‘weaving’ of the mice when they walk, hence the name weaver which is due to a substantial loss of cerebellar granule neurons. These mice also display mild local motor hyperactivity, presumably caused by the degeneration of dopaminergic neurons in the substantia nigra, spontaneous seizures and male sterility.1

    A peptide toxin originating from the Apis mellifera bee venom, Tertiapin (#STT-250) was shown to be a potent blocker of Kir3.2 containing channels (7 nM for Kir3.2 alone and 5.4 nM for the Kir3.1/3.2 combination).4

    Application key:

    CBE- Cell-based ELISA, FC- Flow cytometry, ICC- Immunocytochemistry, IE- Indirect ELISA, IFC- Indirect flow cytometry, IHC- Immunohistochemistry, IP- Immunoprecipitation, LCI- Live cell imaging, N- Neutralization, WB- Western blot

    Species reactivity key:

    H- Human, M- Mouse, R- Rat
    Lyophilized PowderControl Antigen Included
    receive a 25 µl free trial sample!
    Image & Title:

    Anti-GIRK2 (Kir3.2) Antibody
    Expression of GIRK2 in mouse hippocampus.Western blot analysis of mouse hippocampus lysate using Anti-GIRK2 (Kir3.2) Antibody (#APC-006) (upper panels). Note lack of GIRK2 in knockout mice. Immunocytochemical staining of cultured hippocampal mouse neurons with Anti-GIRK2 (Kir3.2) Antibody in wild type cells (upper staining) and Girk2-/- cells (lower staining).Adapted from Marron Fernandez de Velasco, E. et al. (2017) Sci. Rep. 7, 1639. with permission of SPRINGER NATURE.

    Last update: 20/11/2018

    Anti-GIRK2 (Kir3.2) Antibody (#APC-006) is a highly specific antibody directed against an epitope of the mouse protein. The antibody can be used in western blot, immunoprecipitation, immunocytochemistry, and immunohistochemistry applications. It has been designed to recognize Kir3.2 from rat, mouse, and human samples.

    For research purposes only, not for human use
    Citations
    KO validation citations
    1. Immunohistochemical staining of mouse brain sections (1:400). Also tested in GIRK2 conditional knockout mice.
      Honda, I. et al. (2018) Neurosci. Lett. 665, 140.
    2. Western blot analysis of mouse primary hippocampal culture lysate. Immunocytochemical staining of mouse cultured hippocampal neurons. Also tested in Girk2-/- mice.
      Marron Fernandez de Velasco, E. et al. (2017) Sci. Rep. 7, 1639.
    Western blot citations
    1. Mouse brain lysate.
      Tang, X. et al. (2018) Neuroscience 373, 52.
    2. Mouse primary hippocampal culture lysate. Also tested in Girk2-/- mice.
      Marron Fernandez de Velasco, E. et al. (2017) Sci. Rep. 7, 1639.
    3. Mouse hippocampus lysate.
      May, L.M. et al. (2017) Front. Neurosci. 11, 456.
    4. Mouse perirhinal cortex lysate.
      Roncace, V. et al. (2017) Neurobiol. Dis. 106, 89.
    5. Mouse brain lysate.
      Joshi, K. et al. (2016) Ann. Neurol. 80, 511.
    6. Mouse brain lysate (1:200).
      Kotecki, L. et al. (2015) J. Neurosci. 35, 7131.
    7. Mouse brain lysate (1:1000).
      Goodfellow, N.M. et al. (2014) J. Neurosci. 34, 6107.
    8. Mouse brain lysate (1:200).
      Hearing, M. et al. (2013) Neuron 80, 159.
    Immunoprecipitation citations
    1. Mouse brain membrane proteins (1:174).
      Jelacic, T.M. et al. (2000) J. Biol. Chem. 275, 36211.
    Immunohistochemistry citations
    1. Mouse brain sections (1:400). Also tested in GIRK2 conditional knockout mice.
      Honda, I. et al. (2018) Neurosci. Lett. 665, 140.
    2. Monkey brain sections.
      Kikuchi, T. et al. (2017) Nature 548, 592.
    3. Rat brain sections.
      Niclis, J.C. et al. (2017) Stem Cell Reports 9, 868.
    4. Mouse brain sections (1:100).
      Stott, S.R.W. et al. (2017) PLoS ONE 12, e0171748.
    5. Mouse brain sections (1:600).
      Brandalise, F. et al. (2016) Eur. J. Neurosci. 43, 1460.
    6. Rat brain sections (1:500).
      Montandon, G. et al. (2016) Sci. Rep. 6, 32707.
    7. Rat brain sections.
      Seiler, S. et al. (2016) Front. Cell. Neurosci. 10, 87.
    8. Mouse embryo sections.
      Bye, C.R. et al. (2015) Proc. Natl. Acad. Sci. U.S.A. 112, E1946.
    9. Mouse brain sections (1:1000).
      Kotecki, L. et al. (2015) J. Neurosci. 35, 7131.
    10. Mouse brain sections (1:600).
      Bodea, G.O. et al. (2014) Development 141, 661.
    11. Mouse and Rat DRG, sciatic nerve and skin sections (1:200).
      Nockemann, D. et al. (2013) EMBO Mol. Med. 5, 1263.
    12. Human skin sections (1:200).
      Nockemann, D. et al. (2013) EMBO Mol. Med. 5, 1263.
    13. Mouse spinal cords.
      Marker, C.L. et al. (2004) J. Neurosci. 24, 2806.
    Immunocytochemistry citations
    1. Mouse cultured hippocampal neurons. Also tested in Girk2-/- mice.
      Marron Fernandez de Velasco, E. et al. (2017) Sci. Rep. 7, 1639.
    2. hVM1 (human ventral mesencephalic neural stem cell line 1 (1:400).
      Courtois, E.T. et al. (2010) J. Biol. Chem. 285, 9881.
    More product citations
    1. Paik, E.J. et al. (2018) Sci. Rep. 8, 804.
    2. Rivetti di val Cervo, P. et al. (2017) Nat. Biotechnol. 35, 444.
    3. Booker, S.A. et al. (2016) Cereb. Cortex 27, 2318.
    4. Robertson, D.N. et al. (2016) Methods 92, 19.
    5. Booker, S.A. et al. (2013) J. Neurosci. 33, 7961.
    6. Stott, S.R.W. et al. (2013) J. Neurosci. 33, 8022.
    7. Cooper, A. et al. (2012) Proc. Natl. Acad. Sci. U.S.A. 109, 2642.
    8. Ellisor, D. et al. (2012) Dev. Biol.  372, 249.
    9. Maity, B. et al. (2012) J. Biol. Chem. 287, 4972.
    10. Reyes, S. et al. (2012) J. Comp. Neurol.  520, 2591.
    11. Wydeven, N. et al. (2012) Proc. Natl. Acad. Sci. U.S.A. 109, 21492.
    12. Arora, D. et al. (2011) J. Neurosci. 31, 12251.
    13. Deleidi, M. et al. (2011) Stem Cells. 29, 1052.
    14. Lennington, J.B. et al. (2011) J. Neurosci. 31, 13078.
    15. Di Salvio, M. et al. (2010) Nat. Neurosci. 13, 1481.
    16. Grealish, S. et al. (2010) Brain 133, 482.
    17. Nassirpour, R. et al. (2010) J. Neurosci. 30, 13419.
    18. Wakita, S. et al. (2010) J. Neurosci. Methods 192, 83.
    19. Chung, H.J. et al. (2009) Proc. Natl. Acad. Sci. U.S.A. 106, 629.
    20. Friling, S. et al. (2009) Proc. Natl. Acad. Sci. U.S.A. 106, 7613.
    21. Kolk, S.M. et al. (2009) J. Neurosci. 29, 12542.
    22. Iwanir, S. and Reuveny, E. (2008) Pflugers Arch. 456, 1097.
    23. Lignon, J.M. et al. (2008) Physiol. Genomics 33, 230.
    24. Labouèbe, G. et al. (2007) Nat. Neurosci. 10, 1559.
    25. Kulik, A. et al. (2006) J. Neurosci. 26, 4289.
    26. Marker, C.L. et al. (2006) J. Neurosci. 26, 12251.
    27. Huang, C.S. et al. (2005) Cell 123, 105.
    28. Koyrakh, L. et al. (2005) J. Neurosci. 25, 11468.
    29. Marker, C.L. et al. (2005) J. Neurosci. 25, 3551.
    30. Thompson, L. et al. (2005) J. Neurosci. 25, 6467.
    31. Ehrlich, J.R. et al (2004) J. Physiol. 557, 583.
    32. Shankar, H. et al. (2004) Blood 104, 1335.
    33. Davila, V. et al. (2003) J. Neurosci. 23, 5693.
    34. Peleg, S. et al. (2002) Neuron 33, 87.
    35. Torrecilla, M. et al. (2002) J. Neurosci. 22, 4328.
    36. Inanobe, A. et al. (1999) J. Neurosci. 19, 1006.
    37. Pei, Q. et al. (1999) Neuroscience 90, 621.
    38. Kuzhikandathil, E.V. et al., (1998) Mol. Cell. Neurosci. 12, 390.
    39. Schein, J.C. et al. (1998) Dev. Biol. 204, 432.
    Related Products